PHARMACEUTICAL COMPOSITION FOR INHIBITING FORMATION OF THROMBI AND EMBOLI AFTER PLACEMENT OF STENT

摘要

It is intended to provide a novel pharmaceutical composition that can suppress thromboembolism after stent placement. The present invention provides a pharmaceutical composition for the suppression of thromboembolism after stent placement, comprising edoxaban or a pharmaceutically acceptable salt thereof, or a hydrate of the compound or the salt.